Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure.
about
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisBioanalytical techniques for detecting biomarkers of response to human asbestos exposureGuidelines for the diagnosis and treatment of malignant pleural mesotheliomaAssessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum.Diagnostic and prognostic biomarkers for malignant mesothelioma: an update.Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study.Mesothelin (MSLN) methylation and soluble mesothelin-related protein levels in a Chinese asbestos-exposed population.Association of biomarker levels with severity of asbestos-related diseasesHigh prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma.Biomarkers for early detection of malignant mesothelioma: diagnostic and therapeutic application.Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis.Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos.Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma.A predictive equation to adjust for clinical variables in soluble mesothelin-related protein (SMRP) levels.Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers.Biomarkers in the prevention and follow-up of workers exposed to asbestos.Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.
P2860
Q26860736-3618573B-52C3-48FD-8D2C-38703534D364Q28082088-A34D0FE2-2204-455C-A30F-60853A1657B8Q28394028-042BB618-4EE1-4AB9-A295-BA4C84B30D99Q33623718-2B211B76-26F0-42EF-B886-076A9E02EB34Q33890558-99E71748-D498-4C7A-8BBA-E6C2204AD42CQ35904195-BF241E88-8B12-4BFB-B70C-891BA0394969Q35998621-79399E3B-A5ED-43CE-8284-DEC86CA2DC71Q36199410-C3C9F7C6-6316-470E-ABE2-E16876F47FB4Q36397962-53644014-6D77-4087-989A-72024EC183B5Q37328307-DE9D7274-A19D-4002-AEE8-ED8217377907Q37612152-E04E4BF2-0626-47F7-9EA1-F2AB000F26FAQ38118298-EB3FD225-7F00-45C9-827E-FD26DA7690DBQ38415044-5BC37267-7901-4485-A6DD-335408CD9DF9Q41593380-3EA1E4F5-E225-4798-9A48-5EBCA7BFAB84Q41920935-30FFE686-36E1-492B-A194-DA7214B10EC7Q48367339-F2A1874A-979E-4382-8AAA-C0FDCBF7A266Q51206145-5CD10BC5-B0BE-41B5-BE63-D7ED635E7B99Q52672882-6B8210B9-9C67-41AC-BDDC-4AC609D47302Q54678404-62290663-7ECE-4D35-8E5A-FE0BB13BD620Q55026044-F2D989A6-2F1C-4073-B403-59EDF9C0E87C
P2860
Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Serum levels of soluble mesoth ...... n with past asbestos exposure.
@en
Serum levels of soluble mesoth ...... n with past asbestos exposure.
@nl
type
label
Serum levels of soluble mesoth ...... n with past asbestos exposure.
@en
Serum levels of soluble mesoth ...... n with past asbestos exposure.
@nl
prefLabel
Serum levels of soluble mesoth ...... n with past asbestos exposure.
@en
Serum levels of soluble mesoth ...... n with past asbestos exposure.
@nl
P2093
P1476
Serum levels of soluble mesoth ...... n with past asbestos exposure.
@en
P2093
Aida Quero Martínez
Antonio León Jiménez
Carmen Diego Roza
David Rodríguez Rodríguez
Eulogio Rodríguez Becerra
Isabel Isidro Montes
José A Rodríguez Portal
Pilar Cebollero Rivas
P304
P356
10.1158/1055-9965.EPI-08-0422
P577
2009-02-03T00:00:00Z